New product intros (amikacin liposome inhalation suspension (new formulation), anagliptin/metformin hydrochloride (new combination), fruquintinib, gilteritinib, Inotersen, larotrectinib sulfate (first-in-class), lorlatinib, moxetumomab pasudotox-tdfk, omidenepag isopropyl, vibegron)

2018 ◽  
Vol 54 (12) ◽  
pp. 753
Sign in / Sign up

Export Citation Format

Share Document